Thymosin Alpha-1 Dosage Guide
Complete guide to Thymosin Alpha-1 dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
1.6 mg – 3.2 mg
Frequency
Once per week
Route
subcutaneous
Cycle Length
4–12 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Clinical dosing typically ranges from 1.6mg to 6.4mg administered subcutaneously 2-3 times weekly.
Research protocols may vary.
Administration Method
Subcutaneous injection. Often used in cycles or as part of comprehensive immune support protocols.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 2.5 mg/ml
Volume to inject: 0.960 ml
Syringe units: 96.0 units
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with Thymosin Alpha-1 defaults. Adjust values as needed.
Side Effects to Monitor
Generally well-tolerated. Rare side effects include injection site reactions, mild flu-like symptoms, and temporary fatigue.
Safety Considerations & Risks
Should be used cautiously in autoimmune conditions. May interact with immunosuppressive medications. Consult healthcare provider before use.